42 results on '"Henry, Jake Y."'
Search Results
2. Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
3. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
4. CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
5. The T cell differentiation landscape is shaped by tumour mutations in lung cancer
6. Neoantigen-directed immune escape in lung cancer evolution
7. Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
8. Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
9. Supplementary Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
10. Figure from Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
11. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
12. TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
13. CMV promotes recipient T-cell immunity following reduced-intensity T-cell–depleted HSCT, significantly modulating chimerism status
14. Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
15. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
16. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
17. TUMOR IMMUNOLOGY: Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
18. Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
19. A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro
20. Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
21. Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
22. Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide
23. Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
24. Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
25. Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer
26. Neoantigen directed immune escape in lung cancer evolution
27. Fc effector function contributes to the activity of human anti-CTLA-4 antibodies
28. Association of the imbalance between early and late differentiated intra-tumor CD4 T cells with mutational burden in non-small cell lung cancer.
29. Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors
30. Abstract 3812: A best in class anti-CD38 antibody with antitumor and immune-modulatory properties
31. The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells
32. Abstract A127: Innate crosstalk between ILC and interstitial macrophages promotes lung cancer regression in response to IL-12 therapy
33. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
34. Enhanced cross-priming of naive CD8+T cells by dendritic cells treated by the IMiDs®immunomodulatory compounds lenalidomide and pomalidomide
35. Abstract A43: Lenalidomide enhances the anti-proliferative activity of docetaxel inin vivoandin vitromodels of prostate cancer
36. Abstract 5386: Lenalidomide enhances the anti-prostate cancer activity of docetaxelin vitroandin vivo
37. A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro
38. Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMi Ds® immunomodulatory compounds lenalidomide and pomalidomide.
39. Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
40. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
41. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
42. The Heterogeneity of Ly6C hi Monocytes Controls Their Differentiation into iNOS + Macrophages or Monocyte-Derived Dendritic Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.